Woolworths Group announced a disappointing trading update which revealed COVID had weighed heavily on earnings during the first half. The retailer anticipates $215mil in COVID-related expenses and before tax profit to fall from $1.3bn to $1.2bn.
We see value in the stock within the highlighted price range.
Sorry, but this content is restricted to our members.
Please login with your account or register for a free trial. If your trial has expired, then you may renew it here.
If you are having an issue with your account, then please get in touch with us.
VanEck Vectors Global Health Leaders is under Algo Engine buy conditions. We suggest accumulating the fund within the value range indicated below.
Fund Description: HLTH invests in a diversified portfolio of leading international developed markets (ex-Australia)
companies with the best growth at a reasonable price (GARP) attributes from the global healthcare sector with the aim of providing investment returns, before fees and other costs, which track the performance of the Index.
The MarketGrader Developed Markets (ex-Australia) Health Care Net Return AUD Index seeks to identify the largest companies in the healthcare sector with the best GARP attributes, being the best drivers of long-term capital appreciation. The Index constituents are selected on the basis of the strength of their fundamentals across four-factor categories: growth, value, profitability and cash flow.
Woolworths Group announced a disappointing trading update which revealed COVID had weighed heavily on earnings during the first half. The retailer anticipates $215mil in COVID-related expenses and before tax profit to fall from $1.3bn to $1.2bn.
We see value in the stock within the highlighted price range.
Pro Medicus is up 100% since the buy signal back in July 2020.
While the stock trades on a very high multiple 100x FY22 earnings, the 40%+ revenue and profit growth is supported by long-term contract wins. Watch for buying interest to build within the range indicated.
Sorry, but this content is restricted to our members.
Please login with your account or register for a free trial. If your trial has expired, then you may renew it here.
If you are having an issue with your account, then please get in touch with us.
Sorry, but this content is restricted to our members.
Please login with your account or register for a free trial. If your trial has expired, then you may renew it here.
If you are having an issue with your account, then please get in touch with us.
Woolworths Group announced a disappointing trading update which revealed COVID had weighed heavily on earnings during the first half. The retailer anticipates $215mil in COVID-related expenses and before tax profit to fall from $1.3bn to $1.2bn.
We see value in the stock within the highlighted price range.
Collins Foods is under Algo Engine buy conditions. Buying support is likely to increase within the highlighted price range.
Bega recently provided a trading update, with FY22 underlying EBITDA expected to be in the range of
A$195-215mn.
Earnings have been impacted by supply chain-related disruptions, with some offset by the full-year contribution of the Lion Dairy & Drinks acquisition and related cost synergies. FY23 earnings should reaccelerate and recent shareholder support from Andrew Forrest suggests the current price range is a good opportunity to build a position.
Level 29 Chifley Tower
2 Chifley Square
Sydney, NSW 2000
1300 614 002
Investor Signals Pty Ltd
ABN 44 143 555 453
Or start a free thirty day trial for our full service, which includes our ASX Research.